Sherrington Pharmaceuticals Overview
- Year Founded
-
2009
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.69M
Sherrington Pharmaceuticals General Information
Description
Developer of a pain treatment drug. The company develops chronic and refractory pain treatment for end-stage cancer patients and other severe pain indications.
Contact Information
Corporate Office
- 1251 Avenue Of The Americas
- Floor 20
- New York, NY 10020
- United States
Corporate Office
- 1251 Avenue Of The Americas
- Floor 20
- New York, NY 10020
- United States
Sherrington Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 09-Oct-2013 | $1.69M | Completed | Generating Revenue | ||
| 2. Grant | 01-Jan-2010 | Completed | Startup | |||
| 1. Early Stage VC | Completed | Startup |
Sherrington Pharmaceuticals Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Aceras BioMedical | Venture Capital | Minority |
Sherrington Pharmaceuticals FAQs
-
When was Sherrington Pharmaceuticals founded?
Sherrington Pharmaceuticals was founded in 2009.
-
Where is Sherrington Pharmaceuticals headquartered?
Sherrington Pharmaceuticals is headquartered in New York, NY.
-
What industry is Sherrington Pharmaceuticals in?
Sherrington Pharmaceuticals’s primary industry is Pharmaceuticals.
-
Is Sherrington Pharmaceuticals a private or public company?
Sherrington Pharmaceuticals is a Private company.
-
What is the current valuation of Sherrington Pharmaceuticals?
The current valuation of Sherrington Pharmaceuticals is .
-
What is Sherrington Pharmaceuticals’s current revenue?
The current revenue for Sherrington Pharmaceuticals is .
-
Who are Sherrington Pharmaceuticals’s investors?
Aceras BioMedical has invested in Sherrington Pharmaceuticals.
-
When was Sherrington Pharmaceuticals acquired?
Sherrington Pharmaceuticals was acquired on 09-Oct-2013.
-
Who acquired Sherrington Pharmaceuticals?
Sherrington Pharmaceuticals was acquired by Sorrento Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process